Table 2.
Simulated results for screening strategies to prevent hepatocellular carcinoma
| Outcome | No intervention | Two-stage screening | Mass screening using ultrasonography |
| Cost per individual screened, USD | 2755 | 3389 | 3359 |
| Life-year gain1 (yr) | 20.4798 | 20.4926 | 20.4950 |
| Comparing with ICER | |||
| No screening as reference | - | 49733 | 39825 |
| Two-stage screening as reference | - | - | Dominant2 |
1
Screening starting age was 40 years old, screening interval was 1 year;
2
More effective and less costly than reference strategy. ICER: Incremental cost-effectiveness ratio.